DEFINITIVE PROXY

Company

LIGAND PHARMACEUTICALS INC

Filed

December 21, 2005

Period of Report

January 31, 2006

Accession Number

0000936392-05-000462

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →